The Substitution Effect of Fetal Bovine Serum to Platelet-Rich Plasma on Stem Cell Proliferation

Authors

  • Imam Rosadi Mulawarman University
  • Karina Hayandra Clinic, Hayandra Peduli Foundation, Jakarta, Indonesia; HayandraLab, Hayandra Peduli Foundation, Jakarta, Indonesia; Research Center for Regenerative Medicine and Neuroscience, Faculty of Medicine, Universitas Pembangunan Nasional Veteran Jakarta, Jakarta, Indonesia
  • Irsyah Afini
  • Tias Widyastuti
  • Siti Sobariah

DOI:

https://doi.org/10.33477/bs.v13i2.7400

Abstract

Stem cells are capable of self-regeneration and differentiation into specialized cells, such as adipocytes, chondrocytes, and osteocytes. Stem cells can be cultured in vitro using media-containing serum, such as fetal bovine serum (FBS). However, the cell yield is often lacking, thus the manipulation of the culture medium is needed. Platelet-rich plasma (PRP) contains a thousand growth proteins. This study aims to compare the effects of FBS (Gibco), non-commercial PRP, and commercial PLTGold® Human Platelet Lysate (Merck) on the growth and population doubling time (PDT) of stem cells isolated from adipose tissue. Stem cells will be enzymatically isolated from adipose tissue, followed by culture and expansion processes, with subsequent observations of cell morphology, viability, growth rate, and PDT. The results showed that adipose-derived stem cells exhibit fibroblast-like morphology and adhere to the plastic surface. The optimal cell number, PDT and proliferation rate showed in PLTGold®, PRP and FBS respectively. Based on these results, it can be concluded that PLTGold® or PRP can substitute FBS as a growth supplement for stem cell proliferation.

 Keywords: Stem Cell, Proliferation, PDT, PRP, PLTGold®

Downloads

Published

2024-06-25

Issue

Vol. 13 No. 2 (2024): BIOSEL (Biology Science and Education: Jurnal Penelitian Science dan Pendidikan)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.